S2Medical AB (OSTO:S2M) PE Ratio (TTM): At Loss (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is S2Medical AB PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-17), S2Medical AB's share price is kr0.0052. S2Medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.01. Therefore, S2Medical AB's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for S2Medical AB's PE Ratio (TTM) or its related term are showing as below:

OSTO:S2M' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: 1.2   Max: 2.5
Current: At Loss


During the past 10 years, the highest PE Ratio (TTM) of S2Medical AB was 2.50. The lowest was 0.00. And the median was 1.20.


OSTO:S2M's PE Ratio (TTM) is ranked worse than
100% of 436 companies
in the Medical Devices & Instruments industry
Industry Median: 26 vs OSTO:S2M: At Loss

S2Medical AB's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was kr-0.01. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.01.

As of today (2026-07-17), S2Medical AB's share price is kr0.0052. S2Medical AB's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.00. Therefore, S2Medical AB's PE Ratio without NRI for today is At Loss.

During the past 10 years, S2Medical AB's highest PE Ratio without NRI was 2.50. The lowest was 0.00. And the median was 1.20.

S2Medical AB's EPS without NRI for the six months ended in Dec. 2025 was kr-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.00.

During the past 12 months, S2Medical AB's average EPS without NRI Growth Rate was -210.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 74.90% per year.

During the past 10 years, S2Medical AB's highest 3-Year average EPS without NRI Growth Rate was 74.90% per year. The lowest was -133.90% per year. And the median was -16.65% per year.

S2Medical AB's EPS (Basic) for the six months ended in Dec. 2025 was kr-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.01.


S2Medical AB  (OSTO:S2M) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


S2Medical AB PE Ratio (TTM) Related Terms


S2Medical AB PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for S2Medical AB's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

S2Medical AB PE Ratio (TTM) Chart

S2Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss 1.05 At Loss

S2Medical AB Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Dec25
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss 1.05 At Loss

OSTO:S2M vs ISRG, BDX, MDLN: PE Ratio (TTM) Comparison

For the Medical Instruments & Supplies subindustry, S2Medical AB's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S2Medical AB PE Ratio (TTM) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where S2Medical AB's PE Ratio (TTM) falls into.



S2Medical AB PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

S2Medical AB's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=0.0052/-0.010
=At Loss

S2Medical AB's Share Price of today is kr0.0052.
For company reported semi-annually, S2Medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


S2Medical AB Business Description

Other Exchanges S21:Germany
Address Sunnorpsgatan 5, Linkoping, SWE, 582 73
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.